Sep 02, 2020
Prime Therapeutics Introduces Real Time Benefit Check Solution with DrFirst
Aug 03, 2020
Horizon, Prime Therapeutics team with PillPack to improve members' pharmacy experience
Jun 08, 2020
Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets
Apr 23, 2020
Kyle Skiermont to join Prime Therapeutics as senior vice president, specialty pharmacy and home delivery services
Apr 16, 2020
Study Finds Number of Asthma Biologic Medication Users and Spend Doubled Over 2.5 Years
Apr 08, 2020
Prime Therapeutics Welcomes Joseph Leach, M.D. as Chief Medical Officer
Apr 06, 2020
Prime Therapeutics launches PreserveRx(SM) gene therapy financial protection
Mar 30, 2020
Prime Therapeutics Hires Stuart Meyerson to Lead Sales Efforts
Mar 10, 2020
Fast Company Names Prime Therapeutics Among World's Most Innovative Companies for 2020
Jan 09, 2020
David Schlett Joins Prime Therapeutics as Chief Financial Officer
Dec 17, 2019
Prime Therapeutics announces value-based agreement with Pfizer in oncology
Dec 02, 2019
Prime Therapeutics Welcomes Christine Bent as New Chief Operating Officer
Nov 25, 2019
Blue Cross and Blue Shield of Nebraska and Prime Therapeutics Offer New Medicare Advantage Benefit: OTC Discount Card
Oct 29, 2019
Prime Therapeutics Study Finds Tagrisso® New First-line Lung Cancer Treatment Drives Ten-fold Use, $4 Million Cost Increase
Oct 25, 2019
Prime Therapeutics and GuideWell Find Pharmacy Point-of-Sale Alerts Reduce Opioid Overprescribing
Oct 17, 2019
Prime Therapeutics Study Finds Use, Costs for New Migraine Prevention Medications Projected to Triple by 2020
Oct 16, 2019
Prime Therapeutics and Health Care Service Corporation Research: Letters Help Remind Medicaid Members to Take Critical Medicines
Sep 18, 2019
Prime Therapeutics' Proactive Pharmacist Calls, Informed by a Predictive Model, Improved Medicare Member Medication Use
Aug 13, 2019
Kelly McGrail-Pokuta joins Prime Therapeutics as vice president, pharmacy trade relations
Jul 26, 2019
Prime Therapeutics Saved Clients $279 Million through Enhanced Fraud, Waste and Abuse Program